Golden rules for registrars
Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more
They found that if the gene BMAL1, a key component of the body's molecular clock, is deactivated, the body clock stops working and BP, blood glucose levels and metabolism are altered.
The results indicate that altered circadian regulation may increase the risk of cardiovascular disease and diabetes.
It is already known that heart attacks and strokes are more common in the early hours.
The findings could lead to changes in how BP is managed, as the body's response to drugs could also be linked to the body's internal clock.
The researchers used genetic studies in rat models and humans to demonstrate the link between changes in the gene and BP.
Lead researcher Professor Dominique Gauguier, from the University of Oxford, said: 'The regulation of circadian rhythm is central to a wide range of biological processes and this type of genetic study should be extended to other disease areas.'
Comment below and tell us what you thinkQuick search - use * for an abbreviated search, eg nico*
Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more
Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more
Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more
Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more
Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more
Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more
Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more
Comments
Only registered users may comment. Log in now or register for a free account.